
Study Period | 2019 - 2030 |
Market Size (2025) | USD 28.30 Billion |
Market Size (2030) | USD 37.68 Billion |
CAGR (2025 - 2030) | 5.89 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Respiratory Devices Market Analysis
The Global Respiratory Devices Market size is estimated at USD 28.30 billion in 2025, and is expected to reach USD 37.68 billion by 2030, at a CAGR of 5.89% during the forecast period (2025-2030).
Market statistics support the analysis that factors, including air pollution, occupational chemicals, childhood respiratory infections, tobacco smoking, and other environmental influences, are driving a rise in respiratory disorders like COPD, tuberculosis, asthma, and sleep apnea, globally. This surge in respiratory issues is set to propel the growth of the respiratory device market significantly.
Further, the global rise in tuberculosis (TB) cases is poised to boost the respiratory devices market growth in a notable manner. With TB cases surging worldwide, the demand for efficient diagnostic tools and treatment delivery systems has intensified. In regions with high TB infection rates, devices like nebulizers, inhalers, and diagnostic equipment play a pivotal role in managing the disease. For example, data released by the United States Department of Health & Human Services in March 2024 revealed that TB cases in the United States rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. Additionally, the incidence rate saw a jump from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. Given this backdrop, the escalating TB burden underscores a growing demand for respiratory devices, diagnostics, and treatment solutions.
In addition, the high burden of respiratory diseases such as asthma is likely to contribute to the rising demand for respiratory diseases. For instance, the American Lung Association reported in July 2024 that in 2022, 44.2 million Americans were diagnosed with asthma, representing 13.5% of the population. Such statistics underscore the growing need for respiratory devices, fueling the market's expansion during the forecast period.
Additionally, according to a March 2024 article published in Cureus, smoking is a major risk factor for various non-communicable diseases, including lung cancer and chronic respiratory diseases. As tobacco use rises, so does the prevalence of chronic respiratory diseases, leading to heightened demand for respiratory treatment devices. The rising incidence of various respiratory diseases creates a demand for respiratory treatments, propelling the growth of respiratory devices industry over the forecast period.
Also, the launch and regulatory approval of advanced and sophisticated devices for respiratory diseases accentuates the market growth. For instance, in August 2024, Inspire Medical Systems secured FDA approval for its Inspire V neurostimulator therapy, designed for obstructive sleep apnea (OSA).
Consequently, driven by factors like the rising incidence of tuberculosis, asthma, and non-communicable diseases, the analyzed market of respiratory care devices and respiratory therapeutic devices is poised for growth during the forecast period. However, the high cost of devices is expected to hinder the market growth over the forecast period.
Respiratory Devices Market Insights and Trends
Pulse Oximeters Segment is Expected to Witness Significant Growth Over the Forecast Period
The pulse oximeter segment is expected to hold a significant respiratory devices market share, with a compound annual growth rate (CAGR) of 8.15% over the forecast period (2024-2029). This industry report estimates that the segment is expected to have a market value of USD 2.17 billion in 2024 and is likely to reach a market value of USD 2.90 billion by 2029.
A pulse oximeter is a handheld clip device used to measure oxygen saturation. Pulse oximetry is the process of using a device to measure oxygen saturation in the blood by shining light at specific wavelengths through tissue. Deoxygenated and oxygenated hemoglobin absorb light at different wavelengths (660 nm and 940 nm, respectively), and the absorbed light is processed by a proprietary algorithm in the pulse oximeter to display a saturation value.
The growing burden of respiratory disease creates the need for the pulse oximeter for better diagnosis and monitoring. For instance, as per the World Health Organization’s May 2024 update, Asthma is one of the major noncommunicable diseases (NCD) affecting children and adults. Also, it is one of the most common chronic diseases among children. The same source also reported that under-diagnosed and under-treatment of asthma is a significant challenge, particularly in low- and middle-income countries. Such a high burden of disease creates the need for pulse oximeters, which are used in the diagnosis and monitoring of asthma and thus drive the market segment’s growth.
The initiatives taken by the market players such as the development of technically advanced products due to the concerns raised by the various regulatory authorities are also driving the growth of the market segment. For instance, in August 2024, OxiWear secured FDA 510(k) clearance for its innovative ear pulse oximeter, a device tailored for continuous and real-time monitoring of blood oxygen saturation (SpO2) and pulse rate.
Similarly, in February 2024, Masimo revealed that its MightySat Medical received FDA clearance, marking it as the sole FDA-cleared medical fingertip pulse oximeter accessible Over-The-Counter (OTC) directly to consumers without the need for a prescription. In conclusion, the pulse oximeter segment of the respiratory devices industry is poised for significant growth over the forecast period, driven by the increasing burden of respiratory diseases and proactive strategies from manufacturers, including product launches, partnerships, and agreements.

Ventilators Segment in Therapeutic Devices is Expected to Hold a Major Market Share in the Respiratory Devices Industry
Ventilators in the therapeutic devices segment are expected to have a significant market share with a CAGR of 4.62% over the forecast period (2024-2029). This market research estimates that the ventilators segment is expected to have a value of USD 5.56 billion in 2024 within the respiratory devices market and is likely to reach a market value of USD 6.97 billion by 2029.
A ventilator, also known as a breathing machine or respirator, assists individuals in breathing when natural respiration is compromised, such as in cases of severe illness or serious injury.
Patients rely on ventilators to ensure they receive adequate oxygen and effectively expel carbon dioxide. This need arises from various situations, including respiratory diseases, post-surgery recovery, or injuries that impair normal breathing. Factors driving the growth of the ventilators segment in the market include the introduction of advanced and portable ventilators by various players, initiatives from research institutes to conduct research studies on ventilators, and the increasing prevalence of respiratory diseases and surgeries.
The respiratory devices market is divided into type, end user, and geography. By type, the market is segmented into diagnostic and monitoring devices, therapeutic devices, and disposables. By diagnostic and monitoring devices the market is segmented into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and other diagnostic and monitoring devices. By therapeutic devices, the market is segmented into CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and other therapeutic devices. By disposables the market is segmented into masks, breathing circuits, and other disposables. By end user, the market is segmented into hospitals, respiratory clinics and other end users. These segmentations help the stakeholders to focus more on various disease conditions and to produce advanced positive airway pressure devices, monitoring devices, gas analyzers, pulse oximeters, etc.
North America Expected to Witness Significant Respiratory Devices Market Growth
By geography, the North America region is likely to hold a major respiratory devices market share with an estimated market size of USD 10.29 billion in 2024, expected to reach USD 13.22 billion by 2029, with a CAGR of 5.13%. North America is expected to have the largest share throughout the forecast period due to the high burden of Chronic Obstructive Pulmonary Disease (COPD), TB, Asthma, and Sleep Apnea in the region.
In addition, advanced research and development (R&D) facilities are leading to the development of technologically advanced devices, product launches, and partnerships, which are leading to significant market growth.
Growing funding for research in respiratory diseases is likely to drive the respiratory devices market growth in North America by fostering innovation and developing new technologies. Increased financial support enables researchers and companies to explore advanced treatments and diagnostic tools, creating more effective and user-friendly devices. For instance, according to the National Institute of Health, Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), May 2024 update, research funding for COPD is expected to be USD 148 million in 2024 and USD 149 billion in 2025. Therefore, the rising spending on respiratory disease research is expected to boost the development of innovative respiratory devices in the region, further augmenting the market growth during the forecast period.
Market players are expected to drive the nation's growth over the forecast period through strategic initiatives, including product approvals, launches of advanced technologies, and partnerships. For example, Bresotec Medical secured 510(k) clearance from the U.S. Food and Drug Administration in January 2023 for its BresoDX1, a device designed for at-home sleep apnea testing.
Furthermore, the increase in complex respiratory conditions across the region fuels the market growth over the forecast period. For instance, as per the 2023 Annual Report by Asthma Canada, more than 4.6 million Canadians live with Asthma. According to the same source, the economy of asthma patients is projected to cost a total of CAD 4.2 billion (USD 3.0 billion).
Consequently, driven by factors such as increasing government funding and proactive measures by market players including approvals, partnerships, and product launches, the market for respiratory therapeutic devices and respiratory care devices is projected to experience growth in North America during the forecast period.
By geography, the market is segmented into North America (United States, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa), and South America (Brazil, Argentina, Rest of South America). Furthermore, emerging countries like East Africa and other Middle Eastern countries demand advanced medical devices and home care products for pulmonary diseases and sleep apnea to meet the emerging demand, which is expected to propel the market growth over the forecast period.

Respiratory Devices Industry Overview
The competitive landscape of the respiratory devices industry is semi-consolidated, with most players competing to maximize their market shares. Key players in the respiratory devices market research are Asahi Kasei Corporation (ZOLL Medical Corporation), Drive DeVilbiss Healthcare, Dragerwerk AG, Fisher & Paykel Healthcare Ltd., GE Healthcare, Getinge AB, GlaxoSmithKline PLC, Baxter International Inc., Invacare Corporation, Koninklijke Philips NV, Medtronic PLC, ResMed Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd among others.
These pivotal players emphasize technological advancements in their offerings, especially focusing on enhancing the market share and market value of their products. Such concentrated endeavors in market research are set to propel market growth in the foreseeable future.
For instance, in January 2023, OxyGo, renowned for its portable oxygen concentrators, has unveiled a comprehensive sleep line. This new lineup includes a CPAP, BPAP, essential PAP accessories, and a web-based adherence portal. The cloud provider portal offers secure web access for providers to efficiently manage and monitor patient data. Additionally, providers can seamlessly share this data and relevant statistics with physicians and other healthcare professionals. The portal is compatible with 1st-generation OxyGo CPAP and BPAP models through a card-to-cloud system and is set to connect with the newly launched 2nd-generation Wi-Fi models.
Consequently, strategic product launches by key companies are set to drive market growth and influence market trends during the forecast period.
Respiratory Devices Market Leaders
-
DeVilbiss Healthcare LLC
-
Dragerwerk AG
-
Fisher & Paykel Healthcare Ltd
-
GE Healthcare
-
Getinge AB
- *Disclaimer: Major Players sorted in no particular order

Respiratory Devices Market News
- October 2024: Finnish respiratory health innovator WellO2 unveiled its latest breathing exercise device at the Pharmacy Show 2024. Targeted at individuals pursuing drug-free methods to enhance respiratory function, WellO2 asserts that the device delivers validated advantages for those grappling with chronic issues such as asthma, sleep apnea, COPD, and other breathing challenges.
- June 2024: Savara Inc., a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, held a conference to unveil the top-line results from the pivotal Phase 3 IMPALA-2 clinical trial. This trial evaluated the efficacy and safety of molgramostim, an inhaled variant of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), in patients suffering from aPAP.
- June 2024: at the Med-Tech Innovation Expo, Aseptika unveiled the PUFFClicker3, a versatile smart inhaler dose tracker. This innovative device is designed to work seamlessly with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI).
- May 2024: Medline unveiled the Hudson RCI TurboMist, its newest offering in the respiratory care portfolio. TurboMist, touted as the market's quickest small-volume nebulizer, administers medication treatments in just three minutes.
Respiratory Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Respiratory Disorders, Such as COPD, Tb, Asthma, and Sleep Apnea
- 4.2.2 Technological Advancements and Increasing Applications In Homecare Setting
-
4.3 Restraint
- 4.3.1 High Cost of Devices
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value in USD Billion)
-
5.1 By Type
- 5.1.1 Diagnostic and Monitoring Devices
- 5.1.1.1 Spirometers
- 5.1.1.2 Sleep Test Devices
- 5.1.1.3 Peak Flow Meters
- 5.1.1.4 Pulse Oximeters
- 5.1.1.5 Capnographs
- 5.1.1.6 Other Diagnostic and Monitoring Devices
- 5.1.2 Therapeutic Devices
- 5.1.2.1 Cpap Devices
- 5.1.2.2 Bipap Devices
- 5.1.2.3 Humidifiers
- 5.1.2.4 Nebulizers
- 5.1.2.5 Oxygen Concentrators
- 5.1.2.6 Ventilators
- 5.1.2.7 Inhalers
- 5.1.2.8 Other Therapeutic Devices
- 5.1.3 Disposables
- 5.1.3.1 Masks
- 5.1.3.2 Breathing Circuits
- 5.1.3.3 Other Disposables
-
5.2 By End Users
- 5.2.1 Hospitals
- 5.2.2 Respiratory Clinics
- 5.2.3 Other End User
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Asahi Kasei Corporation (ZOLL Medical Corporation)
- 6.1.2 Drive DeVilbiss Healthcare
- 6.1.3 Dragerwerk AG
- 6.1.4 Fisher & Paykel Healthcare Ltd.
- 6.1.5 GE Healthcare
- 6.1.6 Getinge AB
- 6.1.7 GlaxoSmithKline PLC
- 6.1.8 Baxter International Inc.
- 6.1.9 Invacare Corporation
- 6.1.10 Koninklijke Philips NV
- 6.1.11 Medtronic PLC
- 6.1.12 ResMed Inc.
- 6.1.13 Shenzhen Mindray Bio-Medical Electronics Co. Ltd .
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Respiratory Devices Industry Segmentation
As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia.
The respiratory devices market is divided into type, end user and geography. By type, the market is segmented into diagnostic and monitoring devices, therapeutic devices, and disposables. By diagnostic and monitoring devices, the market is segmented into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and other diagnostic and monitoring devices. By therapeutic devices, the market is segmented into CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and other therapeutic devices. By disposables, the market is segmented into masks, breathing circuits, and other disposables. By end user, the market is segmented into hospitals, respiratory clinics and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The report offers the value (in USD Billion) for the above segments. By Type Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Capnographs Other Diagnostic and Monitoring Devices Therapeutic Devices CPAP Devices BiPAP Devices Humidifiers Nebulizers Oxygen Concentrators Ventilators Inhalers Other Therapeutic Devices Disposables Masks Breathing Circuits Other Disposables By Geography North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific Middle East & Africa GCC South Africa Rest of Middle East & Africa South America Brazil Argentina Rest of South America
By Type | Diagnostic and Monitoring Devices | Spirometers | |
Sleep Test Devices | |||
Peak Flow Meters | |||
Pulse Oximeters | |||
Capnographs | |||
Other Diagnostic and Monitoring Devices | |||
Therapeutic Devices | Cpap Devices | ||
Bipap Devices | |||
Humidifiers | |||
Nebulizers | |||
Oxygen Concentrators | |||
Ventilators | |||
Inhalers | |||
Other Therapeutic Devices | |||
Disposables | Masks | ||
Breathing Circuits | |||
Other Disposables | |||
By End Users | Hospitals | ||
Respiratory Clinics | |||
Other End User | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Respiratory Devices Market Research FAQs
How big is the respiratory care devices market?
The global respiratory care devices market size is estimated at USD 28.30 billion in 2025, and is expected to reach USD 37.68 billion by 2030, growing at a CAGR of 5.89% during the forecast period (2025-2030).
What factors are driving growth in the respiratory devices market?
Key market drivers encompass the growing prevalence of respiratory diseases, heightened demand for respiratory devices, and the introduction of technologically advanced products.
What are the different types of respiratory devices?
The different types of respiratory devices include diagnostic and monitoring devices, therapeutic devices, and disposables.
Who are the leading companies in the respiratory devices market?
Key companies in the market are GE Healthcare, Koninklijke Philips N.V., Medtronic PLC, and ResMed Inc., among others.
What are the most common respiratory conditions treated with these devices?
Inhalers and nebulizers play a crucial role in managing respiratory ailments, including asthma and COPD. By administering medication straight to the airways, inhalers offer swift relief during asthma episodes or moments of breathlessness.